Overall Technical outlook

Price Summary

On 2025-10-17, Gland Pharma Limited's shares started at 1923.6, peaked at 1950.3, bottomed out at 1911.8, and ended 0.74% up at 1937.8, with 51686 shares traded.
The highest price the stock achieved in the past 52 weeks is 2102.1, while the lowest price it saw is 1392.8.
According to 11 analysts, the price of GLAND in the future is projected to be between 1630.0 and 2340.0, with an average expected price of 1938.1818.

Technicals

Support and Resistance: The price is currently at 1937.8, supported by 1888.3 and resisted by 1940.3. This indicates a range where 1888.3 may provide a base for the price, while 1940.3 serves as a cap on further upward movement for GLAND.
GLAND supportResistance f863a1
Support/Resistance for GLAND


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
GLAND aroon f863a1
Aroon chart for Gland Pharma Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAND bbands f863a1
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR maintains a bearish outlook, setting a key resistance level that could limit further gains. This resistance reinforces the bearish sentiment, indicating that the market may face challenges in pushing higher.
GLAND psar f863a1
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance for GLAND, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
GLAND stoch f863a1
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The 20, 50, and 100 period moving averages are aligned in a bearish trend for GLAND, with their slopes reinforcing this negative momentum. The downward trajectory of these averages suggests that the market is experiencing sustained bearish pressure. The alignment and consistent downward slopes point to a continuing overall bearish trend, indicating that the market is likely to maintain its downward path.
GLAND trippleSMA f863a1
Tripple SMA chart for Gland Pharma Limited


Before focusing on a company's technical data, such as stock price movements, it's essential to analyze its fundamentals. These include factors like profitability, cash flow, and debt management. Additionally, considering the broader industry landscape—including market trends, competition, and regulatory changes—offers deeper insights. This comprehensive approach allows for a more meaningful interpretation of the company's technical indicators, providing a clearer picture of its financial health and future prospects.